Follow this blog:
RSS

Electroshock therapy secrets unveiled

By | May 18, 2012, 10:38 AM PDT

It’s hard for me to think of electroconvulsive therapy (ECT) without drawing up thoughts of barbarism. How could electrically inducing seizures ever be justified as a way of helping someone feel better?

But, research shows that in cases of severe depression, ECT can outperform any other available form of treatment. Kitty Dukakis, the former first lady of Massachusetts, says the therapy has made her feel better than she had in 22 years of suffering from chronic depression.

ECT has a 70-90% percent rate for improving depression, though it’s typically used as a last resort given its common side effect of memory loss.

Researchers have long assumed that the treatment causes changes in a person’s brain chemistry, but its exact mechanisms have remained unclear.

Pacific Standard reports that a team of British researchers at the University of Aberdeen may have finally uncovered how ECT works.

The Aberdeen team looked at functional MRI scans of people with depression before and after ECT.

Writer Michael Haederle of Pacific Standard explains:

In measuring the connectivity of 25,000 brain areas, researchers found one – the left dorsolateral prefrontal cortex – that appeared to be “hyperconnected” in patients before treatment.

That means for the patients pre-treatment, neurons in their left dorsolateral prefrontal cortex act more in unison than is typical. Haederle continues:

This bolstered an earlier hypothesis, says research fellow Jennifer Perrin, which suggested that in depressed people, cortical structures involved in thinking are too connected to the limbic system that focuses on emotional processing.

The patients showed a decrease in this hyperconnection following ECT, accompanied by an improvement in their depressive symptoms. The researchers’ report concludes:

The findings reported here add weight to the emerging “hyperconnectivity hypothesis” of depression and support the proposal that increased connectivity may constitute both a biomarker for mood disorder and a potential therapeutic target.

This new understanding of possible biomarkers of depression could allow for earlier treatment, pre-empting severe depression. It also provides a target for yet-to-be-developed depression treatments that act through less disruptive means than ECT.

[via Pacific Standard]

(Image: fMRI scan highlighting the left dorsolateral prefrontal cortex via Proceedings of the National Academy of Sciences of the United States of America)

Start your week smarter with our weekly e-mail newsletter. It's your cheat sheet for good ideas. Get it.

Audrey Quinn

About Audrey Quinn

Audrey Quinn is a contributing editor for SmartPlanet.

Audrey Quinn

Audrey Quinn
Contributing Editor

Audrey Quinn is a multimedia science journalist based in Brooklyn, New York. She has corresponded for PRI's The World, Radiolab, Deutsche Welle's Living Planet, and a number of NPR affiliate stations. She also produces and hosts a podcast for the Mind Science Foundation. Previously, she performed neuroscience research at the University of Washington Autism Center and the Seattle VA Hospital.

Follow her on Twitter.

Audrey Quinn

Audrey Quinn

Audrey does not have financial holdings that would influence how or what she covers.

She writes for SmartPlanet and is not an employee of CBS.

If you liked this, don't miss...
The discussion hasn’t started yet. Why don’t you begin it?
Formatting +
BB Codes - Note: HTML is not supported in forums
  • [b] Bold [/b]
  • [i] Italic [/i]
  • [u] Underline [/u]
  • [s] Strikethrough [/s]
  • [q] "Quote" [/q]
  • [ol][*] 1. Ordered List [/ol]
  • [ul][*] · Unordered List [/ul]
  • [pre] Preformat [/pre]
  • [quote] "Blockquote" [/quote]

Join the SmartPlanet community and join the conversation! Signing up is fast and free. Don't wait -- we want to hear your opinion!